News from invo bioscience, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 16, 2022, 16:15 ET INVO Signs Distribution Agreement with Onesky Holding Limited for Mainland China

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

May 16, 2022, 16:05 ET INVO Bioscience Reports First Quarter 2022 Financial Results

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

May 09, 2022, 16:30 ET INVO Bioscience to Report First Quarter 2022 Financial Results on Monday, May 16, 2022

INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

Apr 28, 2022, 09:00 ET INVO Celebrates National Infertility Awareness Week at the INVO Center in Atlanta, Georgia

INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

Apr 14, 2022, 09:00 ET INVO Selects Kansas City as additional INVO Center Location

INVO Bioscience, Inc. (NASDAQ: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

Apr 04, 2022, 09:00 ET INVO Bioscience to Participate in the Lytham Partners Spring 2022 Investor Conference

INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

Mar 31, 2022, 16:05 ET INVO Bioscience Reports 2021 Financial Results

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

Mar 24, 2022, 16:15 ET INVO Bioscience to Report Fourth Quarter and Fiscal Year 2021 Financial Results on Thursday, March 31, 2022

INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

Mar 24, 2022, 09:00 ET INVO Bioscience to Exhibit at the 2022 Pacific Coast Reproductive Society (PCRS) Annual Meeting

INVO Bioscience, Inc. (NASDAQ: INVO), developers of the INVOcell®, an advanced fertility treatment technology which is currently available, is...

Mar 22, 2022, 09:00 ET INVO Bioscience to Participate in Roundtable Discussion at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

Mar 10, 2022, 09:00 ET New Birmingham INVO Center Offers Families an Affordable Advanced Fertility Treatment Solution to Help Combat Rising Costs

INVO Bioscience, Inc. (NASDAQ: INVO), developers of the INVOcell®, an advanced fertility treatment technology which is currently available through a...

Feb 16, 2022, 09:00 ET INVO to Launch Additional INVO Center in Tampa, Florida

INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

Feb 03, 2022, 09:00 ET INVO Bioscience Expands U.S. Commercialization Efforts

INVO Bioscience, Inc. (NASDAQ: INVO) ("Company") ("INVO"), a commercial-stage fertility company focused on expanding access to advanced treatment...

Dec 16, 2021, 09:00 ET INVO Bioscience Enters into Agreement with Ovoclinic in Spain to Expand INVOcell Commercialization

INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®,...

Dec 10, 2021, 14:05 ET INVO Bioscience to Participate in the Lytham Partners Winter 2021 Investor Conference

INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®,...

Dec 01, 2021, 09:00 ET INVO Bioscience Obtains Regulatory Approval to Commercialize INVOcell In Thailand

INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®,...

Nov 15, 2021, 16:05 ET INVO Bioscience Reports Third Quarter 2021 Financial and Operating Results and Provides Business Update

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a medical device company focused on creating alternative treatments for patients...

Nov 09, 2021, 16:15 ET INVO Bioscience to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021

INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Culture System (IVC), INVOcell®,...

Nov 08, 2021, 16:15 ET INVO Bioscience Regains Full U.S. Commercialization Rights

INVO Bioscience, Inc. ("INVO" or the "Company") (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture...

Oct 20, 2021, 09:00 ET INVO Bioscience Announces Four Individual Poster Abstracts Discussing the Benefits of INVOcell Presented at the 2021 American Society for Reproductive Medicine (ASRM) Congress & Expo

INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), ...

Oct 14, 2021, 09:00 ET INVO Bioscience Announces Grand Opening of "Positib Fertility, an INVO Center" in Monterrey, Mexico on November 1, 2021

INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®,...

Oct 01, 2021, 09:29 ET INVO Bioscience Announces $4.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®,...

Sep 09, 2021, 08:00 ET INVO Bioscience Advances INVOcell® Commercialization Efforts With Acquisition in Canada

INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®,...

Sep 07, 2021, 09:00 ET INVO Bioscience Announces Official Opening of "Bloom Fertility, an INVO Center" in Atlanta

INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC), INVOcell®,...

Sep 03, 2021, 09:00 ET Dr. Inger Britt Carlsson, Vice President of Global Medical Affairs for INVO Bioscience, to Present at the 11th Annual AFRH Virtual Conference

INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Culture System (IVC), INVOcell®,...